News
March 28, 2017
Antiva Biosciences Closes $22 Million Series C Financing Read more
August 6, 2015
Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections Read more
August 6, 2015
With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV Read article (Xconomy)
August 6, 2015
Why a longtime biotech exec shunned retirement for a 'breakthrough' Read article (SF Business Journal)
